Imaging and Cerebrospinal Fluid Biomarkers in the Search for Alzheimer's Disease Mechanisms

Publisher： Karger

E-ISSN： 1660-2862|13|2-3|163-165

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.13, Iss.2-3, 2013-10, pp. : 163-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Families with PSEN1 Mutations

By  

Neurodegenerative Diseases, Vol. 8, Iss. 4, 2011-01 ,pp. : 202-207

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the Future

By  

Neurodegenerative Diseases, Vol. 8, Iss. 6, 2011-06 ,pp. : 413-420

Karger

Access to resources Recommend Favorite

The Effect of TOMM40 Poly-T Repeat Lengths on Age of Onset and Cerebrospinal Fluid Biomarkers in Finnish Alzheimer's Disease Patients

By  

Neurodegenerative Diseases, Vol. 14, Iss. 4, 2014-12 ,pp. : 204-208

Karger

Access to resources Recommend Favorite

Differential Functional Connectivity Correlates of Cerebrospinal Fluid Biomarkers in Dementia of the Alzheimer's Type

By  

Neurodegenerative Diseases, Vol. 16, Iss. 3-4, 2015-11 ,pp. : 147-151

Karger

Access to resources Recommend Favorite

S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 6, 2010-06 ,pp. : 373-378

Karger

Access to resources Recommend Favorite